$195.6-293.4k
2+ days a week in office (Sunnyvale, CA)
Genetic testing and DNA analysis
Open for applications
Genetic testing and DNA analysis
501-1000 employees
Open for applications
$195.6-293.4k
2+ days a week in office (Sunnyvale, CA)
501-1000 employees
To help people access, understand, and benefit from the human genome.
Jump to section
To help people access, understand, and benefit from the human genome.
Few candidates hear
back within 2 weeks
10% employee growth in 12 months
23andMe offers its customers a vision into their ancestry and health through genetic testing carried out via kits sent through the mail. Results can show users their risk of more than 50 health conditions thanks to a tube of saliva at one end and a lot of technology at the other.
This access to genetic insight has helped the company sell more than 15 million test kits in the last 15 years. This remains the core component of the business. Access to millions of customers DNA however has given the company a vast collection of genetic material, allowing 23andMe to expanded into the drug development space where it is collaborating with pharmaceutical giant GlaxoSmithKline.
23andMe is not without competition, with other big names including Ancestry and MyHeritage. However, with a valuation of $3.5 billion, it remains one of the largest, with pockets deep enough to pursue many of its growth programs. In mid-2021, the company went public through a SPAC merger with a company founded by Richard Branson. 23andMe intends to use the merger to invest in its health and therapeutics division.
Kirsty
Company Specialist at Welcome to the Jungle
Dec 2020
$82.5m
SERIES F
Jul 2018
$300m
GROWTH EQUITY VC
This company has top investors
Anne Wojcicki
(CEO)They studied Biology at Yale before working as a Healthcare Analyst for Investor AB, Ardsley Partners, Andor Capital, and Passport Capital for a combined 7 years. They leveraged this clinical experience to found 23andMe in 2006.
Marketing
Product